Save 50% on a 3-month Digiday+ membership. Ends Dec 5.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Visa extends its reach into the creator economy’s liquidity crunch
The financial firm is working with creator financial platform Lumanu.
Why Carter’s new CMO wants more emotional, relatable marketing across channels
Carter’s CMO Sarah Crockett joined the company in the summer of 2025 with a goal of doing more realistic, relevant storytelling around childhood and parenting. In an interview with Modern Retail, she shared more about her approach.
U.K. retailer Tesco wants advertisers to see it as equal to any traditional media partner
Tesco’s client development director, Nick Ashley, talked to Digiday about its latest Upfront, the importance of shopper data, as well as how much its ad business impacts profit margins.